Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples